Bacterial viruses against viruses pathogenic for man?

scientific article

Bacterial viruses against viruses pathogenic for man? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VIRUSRES.2005.01.009
P8608Fatcat IDrelease_qxmhiqgqszgb7ljo5rjxbrgg5a
P698PubMed publication ID15845250

P50authorAndrzej GórskiQ9152165
Wojciech FortunaQ73443864
Beata Weber-DąbrowskaQ76447322
Ryszard MiędzybrodzkiQ88907329
P2860cites workBacteriophage therapyQ24550616
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculatureQ24799893
New insights into the possible role of bacteriophages in host defense and diseaseQ24804005
RNA interferenceQ28131798
Identification of virus-encoded microRNAsQ28259309
Mechanisms of gene silencing by double-stranded RNAQ28282560
On the role of RNA amplification in dsRNA-triggered gene silencingQ29617698
A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodiesQ30717070
Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endotheliumQ30790381
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.Q30938337
Uptake and intracellular fate of phage display vectors in mammalian cells.Q31904008
Bacteriophage observations and evolutionQ33187340
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection.Q33200442
Bacterial viruses as human vaccines?Q33205134
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working GroupQ33852247
Cellular receptors for viruses: links to tropism and pathogenesisQ33919202
Filamentous phage as vector-mediated antibody delivery to the brainQ34026070
Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseasesQ34067556
Role of free radicals in viral pathogenesis and mutationQ34191797
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.Q34327996
Long-circulating bacteriophage as antibacterial agentsQ34378378
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infectionQ34465399
The potential role of endogenous bacteriophages in controlling invading pathogensQ34650343
Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in miceQ35120421
Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.Q35182216
Emerging Trends in Oral Delivery of Peptide and Protein DrugsQ35570636
Structure and morphogenesis of bacteriophage T4.Q35587956
RNA-dependent RNA polymerases of dsRNA bacteriophagesQ35686319
Population and evolutionary dynamics of phage therapyQ35709197
RNA silencing: a conserved antiviral immunity of plants and animalsQ35739920
The future of anti-infective products in animal healthQ35752424
Integrin alpha(v)beta(3) mediates rotavirus cell entryQ35852198
Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA.Q35966987
Bacteriophage penetration in vertebratesQ35989564
Treating cocaine addiction with virusesQ36672225
Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virusQ36872657
Immunogenicity of filamentous phage displaying peptide mimotopes after oral administrationQ36880972
Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppressionQ37309793
Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.Q37492531
Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins.Q39550459
The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virusQ39584959
Integrin alphavbeta1 is a receptor for foot-and-mouth disease virusQ39682189
Results of a Five-Year Study of the Curative Effect of Double Stranded Ribonucleic Acid in Viral Dermatoses and Eye DiseasesQ40194264
The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditisQ40410470
Adenovirus inhibition by peptidomimetic integrin antagonistsQ40723509
Lack of Specific Inhibition of Vaccinia Plaque Formation by Bacteriophage Lambda ProductsQ40914842
Oxidative stress during viral infection: a reviewQ41188434
Effect of dsRNA from π6 Bacteriophage on Herpetic Infection in Cell Culture and an Animal ModelQ41663154
Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophageQ42645443
Persistent GB virus C infection and survival in HIV-infected men.Q42983649
Antibiotic use in relation to the risk of breast cancerQ43622802
Human antibody responses to bacteriophage phi X 174: sequential induction of IgM and IgG subclass antibodyQ43770297
Fate of Bacteriophage Lambda in Non-immune Germ-free MiceQ43810260
Bacteriophage collagenQ44360833
Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosisQ44869174
Bacteriophage lambda is a highly stable DNA vaccine delivery vehicleQ44933279
Involvement of integrin alphavbeta3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes.Q45731994
Anti-vaccinia virus effect of M13 bacteriophage DNA.Q45768505
M13 bacteriophage DNA inhibits duck hepatitis B virus during acute infectionQ45778654
Elution and reconcentration of coliphages in water from positively charged membrane filters with urea-arginine phosphate bufferQ46760903
Protection against experimental Newcastle disease in chickens given Brucella bacteriophageQ47682299
Arthritogenic properties of double-stranded (viral) RNA.Q47725563
Dual function of the extracellular matrix: stimulatory for cell cycle progression of naive T cells and antiapoptotic for tissue-derived memory T cells.Q51997996
Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.Q52025614
RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs.Q52592357
Bacteriophage-mediated nucleic acid immunisation.Q53644767
Interferon production by T4 coliphage.Q53814738
Bacteriophage therapy. Stalin's forgotten cure.Q53954501
Characteristics and diffusion in the rabbit of a phage for Escherichia coli 0103. Attempts to use this phage for therapyQ54683984
A member of the immunoglobulin superfamily in bacteriophage T4Q55122145
Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in ratsQ57350390
Differential Inhibition by Phagicin of DNA Synthesis in Cells infected with VacciniaQ59039334
The cytogenetic, proliferative and viability effects of four bacteriophages on human lymphocytesQ67367933
Incorporation of bacteriophage DNA into the genome of cultured human lymphocytesQ71065780
Purification and some possible functions of internal proteins from coliphage T2Q72284353
Oral anti-IgE immunization with epitope-displaying phageQ73281885
"My enemy's enemy is my friend." Using phages to fight bacteriaQ76386512
Fate of bacteriophage particles introduced into mice by various routesQ78297031
P433issue1-2
P304page(s)1-8
P577publication date2005-06-01
P1433published inVirus ResearchQ15749215
P1476titleBacterial viruses against viruses pathogenic for man?
P478volume110

Reverse relations

cites work (P2860)
Q43468019Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes
Q37929756Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens
Q36652581Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria
Q26822719Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection
Q82674431Bacteriophages and transplantation tolerance
Q52639383Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells.
Q54471348Effects of bacteriophages on free radical production and phagocytic functions.
Q41685260Evaluation of nanoparticle tracking analysis for total virus particle determination
Q38225652Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool
Q61449838Perspectives of Phage Therapy in Non-bacterial Infections
Q53694309Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections.
Q38691927Phages and immunomodulation
Q99608826Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection
Q33828309Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention
Q80267832Rapid determination of genomic DNA length for new bacteriophages
Q38888380T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitro
Q46023519The evolving role of infectomics in drug discovery.
Q47269751Therapeutic potential of phages in autoimmune liver diseases